COVID-19/Flu A&B Rapid Immunoassay no ka ʻike pololei

COVID-19/Flu A&B Rapid Immunoassay no ka ʻike pololei,
COVID-19/Flu A&B Rapid Immunoassay no ka ʻike pololei,

Nā kikoʻī huahana

Hoohana Manao
Hoʻohana ʻia ʻo SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit (Lateral chromatography) i hui pū me nā hōʻike lapaʻau a me nā hopena hoʻokolohua ʻē aʻe e kōkua i ka hōʻoia ʻana o nā mea maʻi me ka SARS-CoV-2 a i ʻole Influenza A. /B ma'i.Hoʻohana wale ʻia ka hoʻokolohua e nā limahana lapaʻau.Hāʻawi ia i kahi hopena hōʻike hōʻike mua wale nō a pono e hana ʻia nā ʻano hana hōʻoia ʻē aʻe i mea e loaʻa ai ka hōʻoia ʻana o ka maʻi SARS-CoV-2 a i ʻole Influenza A/B.No ka hoohana oihana wale no.

Kumu Hoao
ʻO SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit (Lateral chromatography) he lateral flow chromatographic immunoassay.Loaʻa iā Windows nā hopena ʻelua.Ma ka hema no nā antigens SARS-CoV-2.ʻElua mau laina i uhi mua ʻia, "T" Test line a me "C" Control line ma ka membrane nitrocellulose.Aia ma ka ʻākau ka puka makani hopena o FluA/FluB, ʻekolu mau laina i uhi mua ʻia, “T1” laina hōʻike FluA, “T2” laina hoʻāʻo FluB a me ka laina Mana “C” ma ka membrane nitrocellulose.

Nā mea nui

Hoʻopaʻa ʻia nā mea i hāʻawi ʻia ma ka papa.

Kahe hana

• KaʻAnuʻu 1: Sampling

E hoʻokuʻu i ke poʻo o ka mea maʻi i 70 degere.E hoʻokomo pono i ka pulupulu i loko o ka puka ihu a hiki i ke kua o ka ihu.E waiho i ka pulupulu i loko o kēlā me kēia puka ihu no 5 kekona e komo i nā mea huna.

• KaʻAnuʻu 2: Hoʻāʻo

1. Wehe i kahi paipu unuhi mai ka kit a me ka pahu ho'āʻo mai ka ʻeke kiʻiʻoniʻoni ma ka haehae ʻana i ka notch.E kau iā lākou ma ka mokulele ākea.

2. Ma hope o ka laʻana, e hoʻoinu i ka hamo ma lalo o ke kiʻekiʻe o ka wai o ka pahu hoʻoheheʻe hoʻohālike, e hoʻohuli a paʻi i 5 mau manawa.Hoʻokomo i ka manawa o ka hamo ma kahi o 15 mau hola.

3. Wehe i ka pulupulu a kaomi i ka lihi o ka paipu e komi i ka wai i loko o ka pulupulu.E kiola i ka ʻōpala i loko o ka ʻōpala pōʻino.

4. E hoʻopaʻa paʻa i ka uhi pipette ma luna o ka paipu hoʻoheheʻe.A laila hoʻohuli mālie i ka paipu hoʻoheheʻe 5 manawa.

5. E hoʻololi i ka 2 i 3 kulu (e pili ana i 100 ul) o ka hāpana i ka ʻili o ka pahu hoʻāʻo a hoʻomaka i ka manawa.'Ōlelo Aʻo: inā hoʻohana ʻia nā laʻana paʻa, pono e loaʻa ka mahana o ka lumi.

• KaʻAnuʻu 3: Heluhelu

Ma hope o 15 mau minuke, e heluhelu i nā hopena me ka ʻike maka.(E hoʻomaopopo: mai heluhelu i nā hopena ma hope o 20 mau minuke!)

Huna Hula

1.SARS-CoV-2 Ka hopena maikaʻi

Hōʻike ʻia nā kaha kala ma ka laina hoʻāʻo (T) a me ka laina hoʻomalu (C).Hōʻike ia a

ka hopena maikaʻi no nā antigens SARS-CoV-2 i ka specimen.

2.FluA Positive Hua

Hōʻike ʻia nā kaha kala ma ka laina hoʻāʻo (T1) a me ka laina hoʻomalu (C).Hōʻike ia

hopena maikaʻi no nā antigens FluA i ka specimen.

3.FluB Positive hopena

Hōʻike ʻia nā kaha kala ma ka laina hoʻāʻo (T2) a me ka laina hoʻomalu (C).Hōʻike ia

hopena maikaʻi no nā antigens FluB i loko o ka specimen.

4.Negative Hua

Hōʻike ʻia ka pūʻulu kala ma ka laina mana (C) wale nō.Hōʻike ia i ka

ʻAʻole i loaʻa ka ʻike o nā antigens SARS-CoV-2 a me FluA/FluB

ma lalo o ka palena ʻike o ka hoʻāʻo.

5. Ka hopena kūpono ʻole

ʻAʻohe pūʻulu kala ʻike ʻia ma ka laina hoʻomalu ma hope o ka hana ʻana i ka hoʻāʻo.ʻO ka

ʻAʻole i hahai pololei ʻia nā kuhikuhi a i ʻole ka hoʻāʻo

deteriorated.Manaʻo ʻia e hoʻāʻo hou i ka specimen.

ʻIke Kauoha

ʻO ka hoʻāʻo COVID-19/Flu A&B kahi immunoassay kahe ʻaoʻao i manaʻo ʻia no ka in vitro wikiwiki, ka manawa like.
ka ʻike ʻana a me ka hoʻokaʻawale ʻana o ka nucleocapsid antigen mai SARS-CoV-2, influenza A a / a i ʻole influenza B pololei mai mua.
ihu a i ʻole nasopharyngeal swab specimens i loaʻa mai nā poʻe, ka poʻe i manaʻo ʻia he maʻi maʻi hanu
kūlike me COVID-19 e kā lākou mea mālama ola, i loko o nā lā ʻelima mua o ka hoʻomaka ʻana o nā hōʻailona.Nā hōʻailona hōʻailona a me
ʻO nā hōʻailona o ka maʻi maʻi hanu ma muli o ka SARS-CoV-2 a me ka maʻi influenza hiki ke like.Ua kaupalena ʻia ka hoʻāʻo ʻana i nā laboratories
i hōʻoia ʻia ma lalo o ka Clinical Laboratory Improvement Amendments o 1988 (CLIA), 42 USC §263a, e hui ana i ka
pono e hana i nā ho'āʻo paʻakikī haʻahaʻa, kiʻekiʻe, a i ʻole waived.Ua ʻae ʻia kēia huahana no ka hoʻohana ʻana ma ka Point of Care
(POC), ʻo ia hoʻi, i loko o nā hoʻonohonoho mālama maʻi e hana ana ma lalo o kahi CLIA Certificate of Waiver, Certificate of Compliance, a i ʻole Certificate of
ʻApono.